Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From March 15th to April 7th, 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with generally accepted scientific standards and described in sufficient detail
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 017
- Report date:
- 2017
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- 1997
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
Test material
- Test material form:
- solid: particulate/powder
Constituent 1
Method
Species / strainopen allclose all
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Species / strain / cell type:
- E. coli WP2 uvr A pKM 101
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 postmitocondrial fraction derived from rat liver, induced by Aroclor 1254 (Concentration of S9 used in the test:10 %)
- Test concentrations with justification for top dose:
- 5, 1.58, 0.5, 0.16, 0.16 and 0.05 mg/plate in main test with and without S9.
In the main test the 5 different bacteria strains were exposed to these 5 concentrations of test substance prepared with a √10 dilution factor. The concentrations were selected according to the preliminary cytotoxicity test performed only on strain TA100 exposed to 5 concentrations. Since no cytotoxicity was observed at 5 mg/plate, the highest concentration allowed in the assay, this solution was used as the first concentration to test in Ames test. - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO was used as solvent.
Controlsopen allclose all
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- 4-nitroquinoline-N-oxide
- 9-aminoacridine
- 2-nitrofluorene
- sodium azide
- other: 4-Nitro-1,2-phenilendiammine and Nitrofurantoine
- Remarks:
- without S9
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- yes
- Positive control substance:
- benzo(a)pyrene
- other: 2-Aminoantracene
- Remarks:
- with S9
- Details on test system and experimental conditions:
- SCREENING OF THE STRAIN BEFORE STARTING WITH TEST: the amino-acid requirement for growth (histidine or tryptophane) is always controlled prior to frozen stock culture preparation as well as the resistance to Ampicillin, the sensitivity to crystal violet and the sensitivity to UV light.
CONTAMINATION OF TEST SUBSTANCE: in order to detect microbial contaminations, 100 µl of the test substance solution 50 mg/ml concentrated, prepared in DMSO, were poured in TSA plate, in duplicate, so that the final concentration of the test substance was 5 mg/plate. It was verified that 50 mg/ml solution prepared in DMSO resulted completely soluble. On the other hand, solution prepared in H2O produced precipitates and for this reason it was not used in the test. Plates were incubated for 5 days at 37 °C ± 1 °C. After the incubation, absence of microbial growth was visually verified. No colonies were detected.
PRELIMINARY CITOTOXICITY TEST: Salmonella typhimurium TA100 (one of the 5 strains that are employed in AMES TEST) was exposed to 5 concentrations of the test substance, in the presence and in the absence of an exogenous metabolic activation system (S9 mix).The survival of treated cultures was determined by verifying the presence of a normal bacterial background. Absent or abnormal background was indicative of a cytotoxic response.
AMES TEST: PLATE INCORPORATION METHOD: suspensions of 5 different bacteria strains were exposed to 5 concentrations of the test substance in the presence and in the absence of an exogenous metabolic activation system (S9 mix). The suspensions were then immediately mixed with an overlay agar and plated onto minimal medium. After two days of incubation at 37 °C, revertant colonies were compared to the number of spontaneous revertant colonies on solvent control plates. In parallel the phenotypic characteristics proper of each strain were confirmed repeating the controls of amino-acid requirement, resistance to Ampicillin, the sensitivity to crystal violet and the sensitivity to UV light.
METHOD OF APPLICATION: plate incorporation method.
DURATION: 48 hours at T= 37 °C ± 1 °C.
NUMBER OF REPLICATIONS: 3 for each concentration for each strain with and without S9.
ACCEPTANCE CRITERIA:
- Acceptability criteria for positive controls: in order to be considered mutagenic, positive controls have to show an increase factor ≥ 2 for TA98, TA100 and WP2 strains, and ≥ 3 for TA1535 and TA1537.
- Acceptance criteria for negative controls: negative controls should show a number of revertant colonies between 15 and 40 for TA98, TA1537 and TA1535 and between 80 and 180 for TA100 and WP2.
- Negative and positive controls should be within the acceptable historical range of the laboratory. - Evaluation criteria:
- For test strains TA98, TA 100 andWP2 the test substance is considered positive and it is able to induce point mutations by base substitutions or frame shifts in the genome of either Salmonella typhimurium and /or Escherichia coli, when, in at least one of the strains TA98, TA100, WP2 and in at least one condition (+S9/-S9) it will induce an Induction Factor ≥ 2. The increase should also be concentration-related. The dose-response correlation will be verified with Dunnet test (alpha = 0.05 1-sided).
For test stains TA1535, TA1537 the test substance is considered positive and it is able to induce point mutations by base substitutions or frame shifts in the genome of either Salmonella typhimurium and/or Escherichia coli, when in at least one of the strains TA1535, TA1537, in at least one condition (S9/-S9) it produces an induction Factor ≥ 3. The increase should also be concentration-related. The dose-response correlation will be verified with Dunnet test (alpha = 0.05 1-sided). - Statistics:
- Mean value and standard deviation (SD) of revertant colonies were calculated for the test solution, the negative and positive controls.
Results and discussion
Test results
- Key result
- Species / strain:
- other: S. typhimurium TA 100, TA 98, TA1535, TA 1537 and E.Coli WP2
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Remarks:
- Preliminary citotoxicity tested only on S. typhimurium TA 100 with and without S9.
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF AMES TEST:
Alter the incubation period, the number of revertant colonies per plate were counted for each dilution of the test substance and for the negative and positive controls. The presence of a bacterial background was also recorded: normal back ground was observed in all plates. Mean value and standard deviation (SD) of revertant colonies were calculated for the test solution, the negative and positive controls. For the test substance and positive controls, the Induction Factor (IF) was calculated as follows: Mean test solution / Mean Respective Negative Control. In all strains the induction factor (IF) did not exceed 2 (TA98, TA100, WP2) or 3 (TA1535, TA1537), hence the substance is not considered mutagenic under the test conditions applied. Notably, it was not necessary to verify the dose-concentration correlation, as no IF increase ≥ 2 or 3 was observed.
RESULT OF PRELIMINARY CITOTOXICITY TEST: No citotoxicity based on background evaluation was in strain TA 100 with and without S9 at any concentration tested of test substance (5, 1.58, 0.5, 0.16 and 0.05 mg/plate). Based on the result of preliminary citotoxicity test the concentration used in the AMES test were selected.
ACCEPTANCE CRITERIA:
- Acceptability criteria for positive controls: fullilled: all positive controls showed an increase factor ≥ 2 for TA98, TA100 and WP2 strains, and ≥ 3 for TA1535 and TA1537.
- Acceptance criteria for negative controls: fullilled: all negative controls showed a number of revertant colonies between 15 and 40 for TA98, TA1537 and TA1535 and between 80 and 180 for TA100 and for WP2.
- Negative and positive controls were within the acceptable historical range of the laboratory.
Applicant's summary and conclusion
- Conclusions:
- The test item is not a mutagenic agent in a bacterial reverse mutation test with and without metabolic activation.
- Executive summary:
The test item was examined for the ability to induce gene mutations in tester strains of Salmonella typhimurium (TA98, TA100, TA1535, TA 1537) and Escherichia coli WP2 uvrA pKM101 with and without metabolic activation S9 according to OECD TG 471.
In all strains the induction factor (IF) did not exceed 2 (TA98, TA100, ECWP2) or 3 (TA1535, TA1537), hence the substance is not considered mutagenic under the test conditions applied. Notably, it was not necessary to verify the dose-concentration correlation, as no IF increase ≥ 2 or 3 was observed.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Kuigi ECHA veebilehe paljud osad on sinu keeles olemas, on see leht osaliselt inglise keeles. Lisateave ECHA mitmekeelsuse kohta.
Tere tulemast Euroopa Kemikaaliameti (ECHA) veebilehele! Internet Explorer 7 (ja varasemad versioonid) ei toeta täielikult seda veebilehte. Uuendage oma Internet Exploreri versiooni.
Sellel veebilehel kasutatakse küpsiseid, et tagada lehe parim kasutus.
Lisateave küpsiste kohta.